Distinct CD4 T-cell effects on primary versus recall CD8 T-cell responses during viral encephalomyelitis

Immunology

Volumn 144, Issue 3, 2015, Pages 374-386

  Hwang, Mihyun ^a   Phares, Timothy W ^a   Hinton, David R ^b   Stohlman, Stephen A ^a   Berg Mann, Cornelia C ^a   Min, Booki ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

CD4 help; CD8 T cells; central nervous system; inflammation

Indexed keywords

EID: 85046015860     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/IMM.12378     Document Type: Article

References (49)

1. + T cells in viral immunity. J Exp Med 2012; 209:1391–5.
2. Schoenberger SP, Toes RE, van der Voort EI, Offringa R, Melief CJ. T-cell help for cyto-toxic T lymphocytes is mediated by CD40–CD40L interactions. Nature 1998; 393:480–3.
3. den Haan JM, Bevan MJ. A novel helper role for CD4 T cells. Proc Natl Acad Sci USA 2000; 97:12950–2.
4. + cytotoxic T-cell responses during chronic viral infection. J Virol 1994; 68:8056–63.
5. Shedlock DJ, Shen H. Requirement for CD4 T cell help in generating functional CD8 T cell memory. Science 2003; 300:337–9.
6. + T cell responses. J Immunol 2014; 192:5214–25.
7. Sun JC, Bevan MJ. Defective CD8 T cell memory following acute infection without CD4 T cell help. Science 2003; 300:339–42.
8. + T lympho-cytes. Nature 2003; 421:852–6.
9. Phares TW, Stohlman SA, Hwang M, Min B, Hinton DR, Bergmann CC. CD4 T cells promote CD8 T cell immunity at the priming and effector site during viral encephalitis. J Virol 2012; 86:2416–27.
10. + T cells. J Immunol 1998; 160:2896–904.
11. + T cells after acute infection. Nat Immunol 2004; 5:927–33.
12. + T-cell help. Nature 2009; 462:510–3.
13. Bergmann CC, Lane TE, Stohlman SA. Coronavirus infection of the central nervous system: host–virus stand-off. Nat Rev Microbiol 2006; 4:121–32.
14. + T-cell expansion and trafficking following central nervous system infection. J Virol 2003; 77:2775–8.
15. Bergmann CC, Parra B, Hinton DR, Ramakrishna C, Dowdell KC, Stohlman SA. Perfo-rin and γ interferon-mediated control of coronavirus central nervous system infection by CD8 T cells in the absence of CD4 T cells. J Virol 2004; 78:1739–50.
16. Lin MT, Stohlman SA, Hinton DR. Mouse hepatitis virus is cleared from the central nervous systems of mice lacking perforin-mediated cytolysis. J Virol 1997; 71:383–91.
17. Parra B, Hinton DR, Marten NW, Bergmann CC, Lin MT, Yang CS, Stohlman SA. IFN-γ is required for viral clearance from central nervous system oligodendroglia. J Immunol 1999; 162:1641–7.
18. Rowe CL, Baker SC, Nathan MJ, Fleming JO. Evolution of mouse hepatitis virus: detection and characterization of spike deletion variants during persistent infection. J Virol 1997; 71:2959–69.
19. Wu GF, Dandekar AA, Pewe L, Perlman S. CD4 and CD8 T cells have redundant but not identical roles in virus-induced demyelination. J Immunol 2000; 165:2278–86.
20. + T cells. J Virol 1990; 64:4589–92.
21. Stohlman SA, Hinton DR, Parra B, Atkinson R, Bergmann CC. CD4 T cells contribute to virus control and pathology following central nervous system infection with neuro-tropic mouse hepatitis virus. J Virol 2008; 82:2130–9.
22. + T cells and RANTES in virus-induced central nervous system inflammation and demyelination. J Virol 2000; 74:1415–24.
23. + T-cell-mediated protection from lethal coronavirus encephalomyelitis. J Virol 2008; 82:12432–40.
24. Bergmann CC, Yao Q, Lin M, Stohlman SA. The JHM strain of mouse hepatitis virus induces a spike protein-specific Db-restricted cytotoxic T cell response. J Gen Virol 1996; 77(Pt 2):315–25.
25. Bergmann C, McMillan M, Stohlman S. Characterization of the Ld-restricted cytotoxic T-lymphocyte epitope in the mouse hepatitis virus nucleocapsid protein. J Virol 1993; 67:7041–9.
26. + T cells during viral persistence in the central nervous system. J Immunol 1999; 163:3379–87.
27. Haring JS, Pewe LL, Perlman S. Bystander CD8 T cell-mediated demyelination after viral infection of the central nervous system. J Immunol 2002; 169:1550–5.
28. Fleming JO, Trousdale MD, el-Zaatari FA, Stohlman SA, Weiner LP. Pathogenicity of antigenic variants of murine coronavirus JHM selected with monoclonal antibodies. J Virol 1986; 58:869–75.
29. Ramakrishna C, Stohlman SA, Atkinson RD, Shlomchik MJ, Bergmann CC. Mechanisms of central nervous system viral persistence: the critical role of antibody and B cells. J Immunol 2002; 168:1204–11.
30. Lin MT, Hinton DR, Marten NW, Bergmann CC, Stohlman SA. Antibody prevents virus reactivation within the central nervous system. J Immunol 1999; 162:7358–68.
31. Gonzalez JM, Bergmann CC, Ramakrishna C, Hinton DR, Atkinson R, Hoskin J, Mack-lin WB, Stohlman SA. Inhibition of interferon-γ signaling in oligodendroglia delays cor-onavirus clearance without altering demyelination. Am J Pathol 2006; 168:796–804.
32. Bergmann CC, Parra B, Hinton DR, Chandran R, Morrison M, Stohlman SA. Perforin-mediated effector function within the central nervous system requires IFN-γ-mediated MHC up-regulation. J Immunol 2003; 170:3204–13.
33. + T cell differentiation during viral infection. Immunity 2007; 27:393–405.
34. + T cell fates via the graded expression of T-bet transcription factor. Immunity 2007; 27:281–95.
35. Kaech SM, Tan JT, Wherry EJ, Konieczny BT, Surh CD, Ahmed R. Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells. Nat Immunol 2003; 4:1191–8.
36. Masopust D, Ha SJ, Vezys V, Ahmed R. Stimulation history dictates memory CD8 T cell phenotype: implications for prime-boost vaccination. J Immunol 2006; 177:831–9.
37. + T cell help. J Immunol 2012; 188:3829–38.
38. + T cell differentiation. J Immunol 2011; 187:4967–78.
39. Cooney LA, Gupta M, Thomas S et al. Short-lived effector CD8 T cells induced by genetically attenuated malaria parasite vaccination express CD11c. Infect Immun 2013; 81:4171–81.
40. Kapil P, Atkinson R, Ramakrishna C, Cua DJ, Bergmann CC, Stohlman SA. Interleu-kin-12 (IL-12), but not IL-23, deficiency ameliorates viral encephalitis without affecting viral control. J Virol 2009; 83:5978–86.
41. Wherry EJ, Barber DL, Kaech SM, Blattman JN, Ahmed R. Antigen-independent memory CD8 T cells do not develop during chronic viral infection. Proc Natl Acad Sci USA 2004; 101:16004–9.
42. Novy P, Quigley M, Huang X, Yang Y. CD4 T cells are required for CD8 T cell survival during both primary and memory recall responses. J Immunol 2007; 179:8243–51.
43. + T cells following infection with herpes simplex virus type 1. J Virol 2009; 83:5256–68.
44. Kapil P, Butchi NB, Stohlman SA, Bergmann CC. Oligodendroglia are limited in type I interferon induction and responsiveness in vivo. Glia 2012; 60:1555–66.
45. Ireland DD, Stohlman SA, Hinton DR, Atkinson R, Bergmann CC. Type I interferons are essential in controlling neurotropic coronavirus infection irrespective of functional CD8 T cells. J Virol 2008; 82:300–10.
46. Xue S, Perlman S. Antigen specificity of CD4 T cell response in the central nervous system of mice infected with mouse hepatitis virus. Virology 1997; 238:68–78.
47. + T cell epitope on nucleocapsid protein which induces different T-helper cell subsets. Virology 1996; 225:339–46.
48. + T cells by IL-21. Eur J Immunol 2010; 40:2990–2.
49. + T-cell memory via TRAIL-mediated activation-induced cell death. Nature 2005; 434:88–93.